Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study.

Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivimäki M; Whitehall II prospective cohort study..

BMJ. 2008 Oct 2;337:a1469. doi: 10.1136/bmj.a1469.

2.

Sickness absence as a global measure of health: evidence from mortality in the Whitehall II prospective cohort study.

Kivimäki M, Head J, Ferrie JE, Shipley MJ, Vahtera J, Marmot MG.

BMJ. 2003 Aug 16;327(7411):364.

3.

Diagnosis-specific sickness absence and all-cause mortality in the GAZEL study.

Ferrie JE, Vahtera J, Kivimäki M, Westerlund H, Melchior M, Alexanderson K, Head J, Chevalier A, Leclerc A, Zins M, Goldberg M, Singh-Manoux A.

J Epidemiol Community Health. 2009 Jan;63(1):50-5. doi: 10.1136/jech.2008.074369. Epub 2008 Nov 27.

4.

Socioeconomic and sex differentials in reason for sickness absence from the Whitehall II Study.

Feeney A, North F, Head J, Canner R, Marmot M.

Occup Environ Med. 1998 Feb;55(2):91-8.

5.

Sickness absence as a predictor of mortality among male and female employees.

Vahtera J, Pentti J, Kivimäki M.

J Epidemiol Community Health. 2004 Apr;58(4):321-6.

6.

A comparison of self-reported sickness absence with absences recorded in employers' registers: evidence from the Whitehall II study.

Ferrie JE, Kivimäki M, Head J, Shipley MJ, Vahtera J, Marmot MG.

Occup Environ Med. 2005 Feb;62(2):74-9.

7.

Influence of change in psychosocial work characteristics on sickness absence: The Whitehall II Study.

Head J, Kivimäki M, Martikainen P, Vahtera J, Ferrie JE, Marmot MG.

J Epidemiol Community Health. 2006 Jan;60(1):55-61.

8.

Organisational downsizing, sickness absence, and mortality: 10-town prospective cohort study.

Vahtera J, Kivimäki M, Pentti J, Linna A, Virtanen M, Virtanen P, Ferrie JE.

BMJ. 2004 Mar 6;328(7439):555. Epub 2004 Feb 23.

9.

All-cause and diagnosis-specific sickness absence as a predictor of sustained suboptimal health: a 14-year follow-up in the GAZEL cohort.

Vahtera J, Westerlund H, Ferrie JE, Head J, Melchior M, Singh-Manoux A, Zins M, Goldberg M, Alexanderson K, Kivimäki M.

J Epidemiol Community Health. 2010 Apr;64(4):311-7. doi: 10.1136/jech.2008.083923. Epub 2009 Aug 13.

10.

Low medically certified sickness absence among employees with poor health status predicts future health improvement: the Whitehall II study.

Kivimäki M, Ferrie JE, Shipley MJ, Vahtera J, Singh-Manoux A, Marmot MG, Head J.

Occup Environ Med. 2008 Mar;65(3):208-10. Epub 2007 Aug 29.

11.

Sickness absence as a measure of health status and functioning: from the UK Whitehall II study.

Marmot M, Feeney A, Shipley M, North F, Syme SL.

J Epidemiol Community Health. 1995 Apr;49(2):124-30.

12.

Does sickness absence due to psychiatric disorder predict cause-specific mortality? A 16-year follow-up of the GAZEL occupational cohort study.

Melchior M, Ferrie JE, Alexanderson K, Goldberg M, Kivimaki M, Singh-Manoux A, Vahtera J, Westerlund H, Zins M, Head J.

Am J Epidemiol. 2010 Sep 15;172(6):700-7. doi: 10.1093/aje/kwq186. Epub 2010 Aug 23.

13.

Occupational burnout and medically certified sickness absence: a population-based study of Finnish employees.

Ahola K, Kivimäki M, Honkonen T, Virtanen M, Koskinen S, Vahtera J, Lönnqvist J.

J Psychosom Res. 2008 Feb;64(2):185-93. doi: 10.1016/j.jpsychores.2007.06.022.

PMID:
18222132
14.

BMI, obesity, and sickness absence in the Whitehall II study.

Ferrie JE, Head J, Shipley MJ, Vahtera J, Marmot MG, Kivimäki M.

Obesity (Silver Spring). 2007 Jun;15(6):1554-64.

15.

Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study.

Hemingway H, Shipley M, Stansfeld S, Shannon H, Frank J, Brunner E, Marmot M.

J Epidemiol Community Health. 1999 Apr;53(4):197-203.

16.

Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study.

Kivimäki M, Head J, Ferrie JE, Singh-Manoux A, Westerlund H, Vahtera J, Leclerc A, Melchior M, Chevalier A, Alexanderson K, Zins M, Goldberg M.

Occup Environ Med. 2008 Dec;65(12):820-6. doi: 10.1136/oem.2007.038398. Epub 2008 Jul 8.

17.

Using repeated measures of sleep disturbances to predict future diagnosis-specific work disability: a cohort study.

Salo P, Vahtera J, Hall M, Rod NH, Virtanen M, Pentti J, Sjösten N, Oksanen T, Kivimäki M.

Sleep. 2012 Apr 1;35(4):559-69. doi: 10.5665/sleep.1746.

18.

Sickness absence for psychiatric illness: the Whitehall II Study.

Stansfeld S, Feeney A, Head J, Canner R, North F, Marmot M.

Soc Sci Med. 1995 Jan;40(2):189-97.

PMID:
7899931
19.

Sickness absence in the Whitehall II study, London: the role of social support and material problems.

Rael EG, Stansfeld SA, Shipley M, Head J, Feeney A, Marmot M.

J Epidemiol Community Health. 1995 Oct;49(5):474-81.

20.

Sickness absence because of musculoskeletal diagnoses and risk of all-cause and cause-specific mortality: a nationwide Swedish cohort study.

Jansson C, Mittendorfer-Rutz E, Alexanderson K.

Pain. 2012 May;153(5):998-1005. doi: 10.1016/j.pain.2012.01.028. Epub 2012 Mar 14.

PMID:
22421427

Supplemental Content

Support Center